The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus
- PMID: 8314502
- PMCID: PMC1374251
- DOI: 10.1136/gut.34.6.727
The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus
Abstract
Smoking and alcohol consumption predispose to oesophageal mucosal damage and exacerbates gastro-oesophageal reflux. The alcohol and smoking habits of patients with severe oesophagitis (n = 24), Barrett's columnar lined oesophagus (CLO) (n = 58), and adenocarcinoma arising in CLO (n = 23) were studied. There was no significant difference between the age (median 67, 64, and 65 years respectively) or duration of symptoms (median 10 years) in each group. Patients with benign CLO were significantly more likely to be non-smokers and non-drinkers, or both than patients with both severe oesophagitis and adenocarcinoma (p < 0.001). Of those who smoked or drank, patients with CLO had a smoking history of a median 15 pack years (range 2-60 pack years), which was less than both the severe oesophagitis (median 45.5, range 5-150 pack years) (p < 0.01), and adenocarcinoma groups (median 55.25, range 4-200 pack years) (p < 0.001). Patients with adenocarcinoma had smoked for more years in total (median 38.5, range 4-54 years) than patients with CLO (median 29.5, range 6-55 years) (p < 0.01). Patients with severe oesophagitis (median 38.5, range 27-55 years) and adenocarcinoma patients had a similar long history of smoking both of which were greater than CLO patients (p < 0.003). Half of the severe oesophagitis group drank more than 40 units/week and six more than 100 units/week (median 40, range 1-->100 units/week), whereas CLO patients who drank did so more moderately (median 10, 1-100 units/week) (p < 0.02). Adenocarcinoma patients also had a somewhat greater alcohol intake than CLO patients, median 15 (1-100 units/week) (p<0.02). Smoking and alcohol consumption do not predispose to the development od metaplastic columnar lined oesophagus in patients with severe gastro-oesophageal reflux but are strongly associated with the development of adenocarcinoma in patients with established Barrett's oesophagus.
Similar articles
-
The relationship between smoking and severe dysplastic disease in patients with Barrett's columnar-lined oesophagus.Eur J Cancer Prev. 2012 Nov;21(6):507-10. doi: 10.1097/CEJ.0b013e328350b06f. Eur J Cancer Prev. 2012. PMID: 22433630
-
Risk factors in the development of esophageal adenocarcinoma.Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18. Am J Gastroenterol. 2013. PMID: 23247577
-
Alcohol consumption pattern and risk of Barrett's oesophagus and erosive oesophagitis: an Italian case-control study.Br J Nutr. 2017 Apr;117(8):1151-1161. doi: 10.1017/S0007114517000940. Epub 2017 May 8. Br J Nutr. 2017. PMID: 28478792
-
Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?Gut. 2005 Mar;54 Suppl 1(Suppl 1):i21-6. doi: 10.1136/gut.2004.041558. Gut. 2005. PMID: 15711004 Free PMC article. Review.
-
Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):17-28. doi: 10.1016/j.bpg.2014.11.002. Epub 2014 Nov 12. Best Pract Res Clin Gastroenterol. 2015. PMID: 25743453 Free PMC article. Review.
Cited by
-
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.World J Surg. 2003 Sep;27(9):999-1008; discussion 1006-8. doi: 10.1007/s00268-003-7052-2. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917764 Review.
-
Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population.World J Gastroenterol. 2014 Sep 14;20(34):12212-6. doi: 10.3748/wjg.v20.i34.12212. World J Gastroenterol. 2014. PMID: 25232254 Free PMC article.
-
Effects of phenylethyl isothiocyanate on early molecular events in N-nitrosomethylbenzylamine-induced cytotoxicity in rat esophagus.Cancer Res. 2007 Jul 1;67(13):6484-92. doi: 10.1158/0008-5472.CAN-06-4531. Cancer Res. 2007. PMID: 17616710 Free PMC article.
-
Clinical implications of molecular changes in pediatric Barrett's esophagus.Curr Gastroenterol Rep. 2012 Jun;14(3):253-61. doi: 10.1007/s11894-012-0252-x. Curr Gastroenterol Rep. 2012. PMID: 22373715 Review.
-
Cost effectiveness of detecting Barrett's cancer.Gut. 1996 Oct;39(4):574-9. doi: 10.1136/gut.39.4.574. Gut. 1996. PMID: 8944568 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical